Navigation Links
Abingworth Appoints David Mayer as Partner
Date:4/29/2008

LONDON and BOSTON, April 29 /PRNewswire/ -- Abingworth, the international life sciences investment group, today announced the appointment of David Mayer as Partner. He will be based at the Company's offices in Waltham, MA, USA and his prime responsibility will be to support Abingworth's efforts in growth equity, which will include expansion and acquisition financings, small buyouts and build-ups in healthcare and life science companies. Abingworth plans to invest from 10 million pounds Sterling ($20 million) to up to 40 million pounds ($80 million) in each of its growth equity investments.

Mr. Mayer adds significant depth and expertise to Abingworth with more than 12 years experience in growth equity/buyouts, of which 8 years have been spent focused on the healthcare sector. Mr. Mayer was most recently a Managing Partner at Thoma Cressey Equity Partners (TCEP). He was one of five Managing Partners at TCEP, which managed more than $1.75 billion in capital, and he opened their Boston office in 2004. He was also responsible for expanding the areas within healthcare in which the firm now invests to include pharmaceuticals and medical products, in addition to healthcare services. Notable investments made during his time at TCEP include: ESP Pharma, Inc., Jazz Pharmaceuticals, Inc., Critical Care Systems, Inc., Essent Healthcare, Inc. and Continuing Care RX, Inc.

"We are delighted to welcome Dave to our investment team," said Stephen Bunting, Managing Partner of Abingworth. "He has a proven track record in growth equity and has served on the boards of several healthcare and life science companies. His broad network of contacts and extensive experience will provide valuable strategic support to our investment process and to our portfolio companies. We believe he is an excellent fit with our organization."

David Mayer said, "I am very pleased to be joining Abingworth, one of the pioneering investment firms in the life sciences area, and I look fo
'/>"/>

SOURCE Abingworth
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. MIGENIX Appoints Pieter Dorsman to Board of Directors
2. Anavex appoints Dr. Dimitri Goundis to lead Clinical Development
3. Phytomedics Inc. Appoints Dr. Laurie Smaldone Alsup, MD., as President and Chief Executive Officer
4. Metabolex Appoints Donald Hill as Chief Financial Officer
5. Biopure Appoints New Independent Auditor
6. Indivumed Appoints Annette Kassen as Vice President Clinical Research
7. ADVENTRX Appoints Vice President of Manufacturing
8. Egenix, Inc. Appoints Dr. Daniel Petrylak Chairman of Scientific Advisory Board
9. NanoLogix Inc. Provides Financial Update, Appoints Bert Pharis as New Director
10. Observant LLC Appoints Two New Directors to the Senior Management Team
11. Immune Tolerance Institute Appoints Aaron B. Kantor Ph.D. Chief Scientific Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...N, Nov. 25 Biotech firm Replikins ...ata from the 1918 pandemic through the prediction,...ic, today issued its latest biochemical analysis o... of the H1N1 ("Swine Flu") virus has dropped from ...ent outbreak in the spring of 2009 to resting non-...
(Date:11/25/2009)..., Nov. 25 /PRNewswire/ - Cytochroma today announce... of Directors. Dr. Moldt will replace Mr. Ulrik Sp...s Board. The number of Board members remains uncha... welcome Peter Moldt to the board and look forward... Cytochroma continues to make progress in becoming...
(Date:11/25/2009)... Nov. 25 Ardea Bioscienc...ry D. Quart, Pharm.D., president and chief executi... Annual Health Care Conference. , ,Presentation d...Health Care Conference,Date: Tuesday, Decembe...on: The New York Palace Hotel, New York, NY,Webca...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...: David Appia, French Ambassador for International... France Agency, , , , ,What: Ambassador Appia is ...-business initiatives adopted by France to further...ape for innovation and development., , ,When: Avai...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...ram to Launch at the Annual Oncology Nursing Socie... Amgen (Nasdaq: AMGN ) and ONS Edge , a subsidi...nnounced that they will partner alongside celebrit...upport a new educational campaign, Coping with Ca... at educating oncology nurses about the skin-relat...
...ceuticals, Inc., a privately held drug development...sented on its novel molecule, AFP-464, during the ..."This research represents a significant advancemen...r, one of the most aggressive forms of invasive br...resident and Chief Executive Officer of Tigris. ...
...rtible debentures of Victhom , to be completed by ...PRNewswire-FirstCall/ - Victhom Human Bionics Inc....bH ("Otto Bock") announced today the execution on ...lish a joint venture to develop and commercialize ...urobionix division. , The objective of this joint ...
Other Biology Technology:Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 2Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 3Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 4Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 5Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign 6Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 2Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 3Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting 4Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 2Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 3Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 4Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 5
(Date:11/30/2009)...ilable in German . , The DFG has approved t...Centres as of 1 January 2010. This decision was ma...nn. The new centres will initially be funded for f..., 20 percent overhead funding for indirect costs w..., research topics range from modern prostheses to ...
(Date:11/30/2009)...Journal of Experimental Biology are pleased to an...de la Recherche Scientifique (CNRS) in the Univers...year,s JEB Outstanding Paper Prize. ,The prize i...ment and is intended to encourage young scientists... and adds that ,we truly appreciate when authors s...
(Date:11/30/2009)...es continue to rise scientists are presented with ... respond and adapt. In a paper published in Insec...uez-Trelles and Dr Miguel Rodriguez assess this ch...pproximately 0.6˚C has already affected the E...ologists and evolutionary biologists is to predict...
Breaking Biology News(10 mins):DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4How can scientists measure evolutionary responses to climate change? 2REPEL CV 28TM 29 Adhesion Barrier Receives Endorsement of Kids With Heart 13453 1REPEL CV 28TM 29 Adhesion Barrier Receives Endorsement of Kids With Heart 13453 2Slide Into Debt Could Bring Wider Waistline 53941 1Slide Into Debt Could Bring Wider Waistline 53941 2Electronic Health Records Help Cardiac Patients Remain Healthy 53938 1Electronic Health Records Help Cardiac Patients Remain Healthy 53938 2Electronic Health Records Help Cardiac Patients Remain Healthy 53938 3Electronic Health Records Help Cardiac Patients Remain Healthy 53938 4
...on for the development of allergy may be malfuncti...ergens to bind to, enter and travel through the ep...n this subject have recently been published in two...and (2) Journal of Allergy and Clinical Immunolog...focused on the understanding of aberrant immunores...
...le, MA -- Three leading research centers based in ...f the Woods Hole Consortium, a new alliance that w...on some of the major issues facing society today a...the South Coast of Massachusetts. , The consortiu...atory (MBL), Woods Hole Oceanographic Institution ...
...Ind. A new study in the The Journal of Applied P...y their workouts to avoid extensive muscle loss du...ion (ISS). , The latest NASA-sponsored research f...ratory (HPL) suggests that changes are needed to o...ts to improve their muscle performance while in sp...
Other Biology News:Malfunction of the respiratory epithelium is a cause of allergy? 23 Woods Hole scientific institutions forge alliance to address societal issues 23 Woods Hole scientific institutions forge alliance to address societal issues 3Astronauts may need more intense workouts to maintain muscle fitness in space 2
...Microdissection (LCM) is the method of choice for ...issection is the only instrument to offer both LCM...y., UV Laser Cutting provides unprecedente...es and capturing large numbers of cells. , LCM ...
Hybridizer (220 V) from Dako
...00 System is an automated multiplexing platform th...ing SNP detection, pathogen sequence detection and...ith multiple targets can be applied to an open and...ridge, which may be reused until all tests sites h...
Bio-Plex Manager Version 3.0 to 4.0 Workstation Software Upgrade Kit from Bio-Rad
Biology Products: